Epigenetic Control of Melanoma by MAGE Transcription Factors

MAGE 转录因子对黑色素瘤的表观遗传控制

基本信息

项目摘要

Melanoma develops as melanocytes accumulate genetic and epigenetic abnormalities, typically causing oncogene activation and senescence, followed by escape from senescence and loss of tumor suppression. Members of the Class I MAGE gene family are normally expressed only in developing germ cells and placenta but their expression is activated in many malignancies including melanoma. Class I MAGE protein expression is associated with poor clinical outcomes and resistance to treatment, and knockdown of MAGE proteins increases melanoma cell apoptosis in vitro and decreases growth of MAGE (+) human melanoma cells in immunocompromised mice, suggesting that MAGE proteins play important functional roles in melanoma biology. MAGE proteins bind to and regulate KAP1, a scaffolding protein and ubiquitin E3-ligase that causes localized chromatin compaction and represses gene expression when recruited to specific DNA sites by KRAB-zinc finger transcription factors (KZFs), the largest group of transcription factors in vertebrates. MAGE proteins modify KZF-KAP1 binding to and repression of specific genes, and MAGE expression affects Id1, AP2 and p16, all known to be involved in melanocytic transformation. However, the specific roles of MAGE proteins in the biology of melanoma, their mechanisms of action, and ways to exploit them for treatment have not been not fully characterized. Our overall goal is to understand the role of Class I MAGE expression in melanoma development. We will test the hypothesis that MAGE proteins facilitate melanocyte transformation by regulating expression of genes that cooperate to promote escape from senescence, and increase melanocyte proliferation and tissue invasion. Aim 1: To determine how MAGE affects melanocyte growth and tissue invasion. Aim 1a will test whether MAGE promotes escape from BRAFV600E induced senescence by suppressing p16 via Id1, using selective knockdown of endogenous Id1, p16 and MAGE in BRAFV600E (+) cells, or by ectopic expression of BRAFV600E , Id1, p16, and MAGE, followed by measurement of cell growth and senescence markers. Epigenetic effects of MAGE will be determined by ChIP for MAGE and histone 3 trimethylated on leucine 9 (H3me3K9), a molecular signature of KAP1 induced gene repression. Aim 1b will use a similar strategy to test whether MAGE regulation of AP2 promotes migration and invasion of melanocytes in Boyden chamber and in vitro wound assays. Aim 2: To establish in vivo associations of MAGE expression with melanocyte transformation. This Aim will use state of the art multispectral immunohistology with a unique tissue microarray to test the hypothesis that MAGE is expressed early in melanocyte transformation and that MAGE proteins co-localize with markers of proliferation (Ki67) and are inversely correlated with expression of senescence markers. Aim 3: To test the hypothesis that MAGE expression promotes melanocyte transformation in vivo. Aim 3a will determine whether MAGE affects melanocyte migration or tissue invasion in utero using immunohistology and unique transgenic mice that express melanocyte specific, doxycycline inducible MAGE. Aim 3b will test the hypothesis that MAGE promotes melanocyte transformation by crossing melanocyte MAGE (+) mice into BRAFV600E or NRASQ61K based murine models of oncogene induced melanocytic nevi. Aim 3c will determine the effects of MAGE-A3 expression in early melanoma by crossing MAGE transgenics into melanoma models expressing BRAFV600E or NRASQ61K and showing loss of tumor suppressors PTEN or p16. Outcomes include the rate of transformation, number, and histologic characteristics of resulting melanomas. Assessment of MAGE repression of individual genes will use ChIP, reverse transcription real time quantitative PCR (RT-qPCR) and protein immunoblotting. These studies will benefit veterans by identifying novel targets for treatment and prevention of melanoma.
黑色素瘤的发展是由于黑色素细胞积累遗传和表观遗传异常,通常导致

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

B Jack Longley其他文献

B Jack Longley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('B Jack Longley', 18)}}的其他基金

Epigenetic Control of Melanoma by MAGE Transcription Factors
MAGE 转录因子对黑色素瘤的表观遗传控制
  • 批准号:
    9898234
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
The Cutaneous Biology of MAGE Transcription Factors
MAGE 转录因子的皮肤生物学
  • 批准号:
    8385968
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
The Cutaneous Biology of MAGE Transcription Factors
MAGE 转录因子的皮肤生物学
  • 批准号:
    8497632
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
Cutaneous Biology of KIT Ligand
KIT 配体的皮肤生物学
  • 批准号:
    6949039
  • 财政年份:
    1997
  • 资助金额:
    --
  • 项目类别:
Cutaneous Biology of KIT Ligand
KIT 配体的皮肤生物学
  • 批准号:
    6755162
  • 财政年份:
    1997
  • 资助金额:
    --
  • 项目类别:
Cutaneous Biology KIT Ligand
皮肤生物学 KIT 配体
  • 批准号:
    7261475
  • 财政年份:
    1997
  • 资助金额:
    --
  • 项目类别:
Cutaneous Biology of KIT Ligand
KIT 配体的皮肤生物学
  • 批准号:
    6667090
  • 财政年份:
    1997
  • 资助金额:
    --
  • 项目类别:
Experimental Cutaneous Pathology Core
实验皮肤病理学核心
  • 批准号:
    8926360
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Experimental Cutaneous Pathology Core
实验皮肤病理学核心
  • 批准号:
    9135131
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Experimental Cutaneous Pathology Core
实验皮肤病理学核心
  • 批准号:
    8753351
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Apoptosis regulation by RNA binding proteins
RNA 结合蛋白的细胞凋亡调节
  • 批准号:
    DDG-2015-00002
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
    Discovery Development Grant
Apoptosis regulation by RNA binding proteins
RNA 结合蛋白的细胞凋亡调节
  • 批准号:
    DDG-2015-00002
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
    Discovery Development Grant
Mechanisms Of RNA-Binding Protein-Mediated Apoptosis In Oral Mucositis
RNA结合蛋白介导的口腔粘膜炎细胞凋亡机制
  • 批准号:
    9237260
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Mechanisms Of RNA-Binding Protein-Mediated Apoptosis In Oral Mucositis
RNA结合蛋白介导的口腔粘膜炎细胞凋亡机制
  • 批准号:
    8657030
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Apoptosis regulation by RNA binding proteins
RNA 结合蛋白的细胞凋亡调节
  • 批准号:
    261206-2009
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Mechanisms Of RNA-Binding Protein-Mediated Apoptosis In Oral Mucositis
RNA结合蛋白介导的口腔粘膜炎细胞凋亡机制
  • 批准号:
    8993725
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Mechanisms Of RNA-Binding Protein-Mediated Apoptosis In Oral Mucositis
RNA结合蛋白介导的口腔粘膜炎细胞凋亡机制
  • 批准号:
    8503886
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Apoptosis regulation by RNA binding proteins
RNA 结合蛋白的细胞凋亡调节
  • 批准号:
    261206-2009
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
The binding and apoptosis inhibitory action to germ cells of relaxin-like peptide expressed in the boar testis
公猪睾丸表达的松弛素样肽与生殖细胞的结合及凋亡抑制作用
  • 批准号:
    24580408
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of the Insulin-like Growth Factor 2 mRNA Binding Protein (IGF2BP1) as an important regulator of cIAP1 translation and apoptosis in Rhabdomyosarcomas
鉴定胰岛素样生长因子 2 mRNA 结合蛋白 (IGF2BP1) 作为横纹肌肉瘤中 cIAP1 翻译和细胞凋亡的重要调节因子
  • 批准号:
    269093
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了